HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew R Belch Selected Research

Andrew R Belch Research Topics

Disease

25Multiple Myeloma
01/2021 - 02/2002
17Neoplasms (Cancer)
09/2014 - 07/2002
7Waldenstrom Macroglobulinemia (Macroglobulinemia)
12/2008 - 04/2003
3Disease Progression
09/2014 - 06/2005
3Monoclonal Gammopathy of Undetermined Significance
01/2013 - 04/2006
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2015 - 02/2013
2Breast Neoplasms (Breast Cancer)
09/2014 - 01/2014
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2017
1Infections
09/2014
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
06/2014
1Lymphoma (Lymphomas)
06/2014
1Carcinogenesis
05/2013
1Leukemia
02/2013
1Residual Neoplasm
07/2007
1Testicular Neoplasms (Testicular Cancer)
11/2005
1Synovial Sarcoma (Synovioma)
11/2005
1Paraproteinemias (Monoclonal Gammopathy)
03/2005
1Aneuploidy (Aneuploid)
10/2002
1Hodgkin Disease (Hodgkin's Disease)
07/2002

Drug/Important Bio-Agent (IBA)

8Hyaluronan SynthasesIBA
01/2014 - 04/2003
7Immunoglobulin M (IgM)IBA
09/2008 - 02/2002
5Hyaluronic Acid (Hyaluronan)IBA
01/2014 - 04/2003
5Proteins (Proteins, Gene)FDA Link
11/2005 - 07/2002
4Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2015 - 10/2005
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 01/2009
3Immunoglobulins (Immunoglobulin)IBA
06/2014 - 03/2002
3RNA Precursors (Precursor, mRNA)IBA
01/2014 - 01/2013
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 06/2014
2Prednisone (Sone)FDA LinkGeneric
06/2014 - 12/2004
2Indicators and Reagents (Reagents)IBA
05/2013 - 06/2005
2DNA (Deoxyribonucleic Acid)IBA
10/2005 - 10/2002
1carfilzomibIBA
01/2021
1AntibodiesIBA
01/2017
1Lenalidomide (CC 5013)FDA Link
09/2014
1Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
09/2014
1Vincristine (Oncovin)FDA LinkGeneric
06/2014
1CytokinesIBA
01/2013
1Polo-Like Kinase 1IBA
12/2011
1Fibronectins (Fibronectin)IBA
03/2009
1Laminin (Merosin)IBA
03/2009
1CollagenIBA
03/2009
1Bortezomib (Velcade)FDA Link
01/2009
1Aurora Kinase BIBA
02/2008
1Aurora Kinase AIBA
02/2008
12- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA
02/2008
1Aurora KinasesIBA
02/2008
1Rituximab (Mabthera)FDA Link
01/2008
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
07/2007
1Cytidine DeaminaseIBA
04/2006
1AntigensIBA
11/2005
1VaccinesIBA
11/2005
1Cancer VaccinesIBA
11/2005
1Carrier Proteins (Binding Protein)IBA
05/2005
1Thalidomide (Thalomid)FDA Link
12/2004
1Protein Isoforms (Isoforms)IBA
08/2004
1GemcitabineFDA Link
07/2002
1NucleosidesIBA
07/2002
1Equilibrative Nucleoside Transporter 1IBA
07/2002

Therapy/Procedure

6Therapeutics
09/2014 - 12/2004
2Drug Therapy (Chemotherapy)
06/2014 - 02/2013
1Stem Cell Transplantation
09/2014
1Immunotherapy
06/2014
1Salvage Therapy
08/2008
1Ambulatory Care (Outpatient Care)
10/2005